Advances in Pulmonology and Lung Surgery

Among the top pulmonology & lung surgery hospitals in New York and the country.

Our program is led by renowned physicians and a comprehensive multidisciplinary team. With expert leadership, a strong research component, and unsurpassed patient survival rates, our lung transplantation program has been top-ranked in the Nation for the past 10 years.

Medical illustration showing lung cancer.

Transforming Care: A Minimally Invasive Approach to Lung Biopsy

A Columbia pulmonologist is changing the paradigm of care for patients with lung nodules made possible by the emerging field of interventional pulmonology.

3D illustration of lung anatomy

Plasma EV-miRNAs: Are They Viable Biomarkers of Premature Lung Injury?

A Columbia pulmonologist evaluates the associations of plasma extracellular vesicle-encapsulated microRNAs with lung function that may lead to early identification and treatment of patients at risk of developing lung disease.

CT scan of emphysema in a person living with HIV

Can a Common Antibiotic Slow Progression of Emphysema in Persons with HIV?

Weill Cornell Medicine pulmonologist and infectious disease specialist collaborate on an NIH-funded phase 2 clinical trial to test if doxycycline will slow progression of emphysema in people with HIV.

vector illustration of ECMO

ECMO and Early Mobilization: When is it Feasible and Safe?

A Columbia medical intensivist and specialist in extracorporeal membrane oxygenation presents factors associated with intensity of treatment for patients in cardiopulmonary failure.

Abstract illustration of lungs, molecule structure

Idiopathic Pulmonary Fibrosis: Rare Variants Link a New Gene and Pathway to Disease

Columbia physician-scientists in pulmonology uncover a new gene and a new pathway responsible for the development of IPF.

Thoracic scan of respiratory insufficiency caused by diffuse interstitial pulmonary fibrosis

Pragmatic Trial Design Provides New Structure for Studies in IPF

Weill Cornell Medicine pulmonologist and lead investigator reflects on the completion of the CleanUP-IPF clinical trial as a valid design for studying idiopathic pulmonary fibrosis.

image of three CT scan of lung following COVID-19 with and without abnormalities

COVID-19: Investigating the Persistence of Severe Respiratory Symptoms

Columbia pulmonary and critical care medicine faculty partner with radiologists to study enduring pulmonary consequences in patients following hospitalization for SARS-CoV-2.

image of bacteria Streptococcus pneumoniae, or pneumococcus

An Expert Makes the Case for Pneumococcal Vaccinations

Weill Cornell Medicine pulmonologist leads a comprehensive review of effectiveness and efficacy of the 23-valent polysaccharide vaccine.

image of lung cells damaged by COVID-19 undergoing analysis

Novel Technique Provides Insights into Lung Pathology in COVID-19

Investigators at Weill Cornell Medicine and NewYork-Presbyterian used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases.

vector image of coronavirus

COVID-19: One Year Later

Pulmonologists and critical care medicine specialists at NewYork-Presbyterian Hospital, Columbia University, and Weill Cornell Medicine continue to share their observations and present their research findings on severe acute respiratory syndrome coronavirus 2.

image of Dr. Selim M. Arcasoy

Lung Transplantation: Decades of Experience and Expertise

Since the inception of the new program nearly two decades ago, the Lung Transplantation Program at NewYork-Presbyterian/Columbia has performed more than 900 lung transplants with survival rates that far surpass national averages.

image of Dr. Sanja J. Jelic

Sleep and Cardiovascular Risk: A Causal Relationship?

Sleep is increasingly recognized as an important contributor to health, yet many Americans regularly do not get enough sleep. To learn if inadequate sleep increases their risks of heart disease, NYP Columbia study the relationship between sleep habits and cardiovascular risk factors.

image of Dr. Robert J. Kaner

IPF: Looking to the Microbiome for New Treatments

Despite years of investigations, the origin of idiopathic pulmonary fibrosis has remained elusive. Researchers at NewYork-Presbyterian/Weill Cornell are looking into new therapies to slow the progression.

Newsletters for Medical Professionals

2022 Issue 1

2021 Issue 2

2021 Issue 1

2018 Issue 2

2018 Issue 1

2017 Issue 1

Spring/Summer 2016